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Conclusions: Preliminary results show an overall equivalence 
among different techniques in planning of hypofractionated 
prostatic treatments with concomitant boost. Further 
analysis will include time of treatments and NTCP 
calculation. In order to enrich the statistical analysis, plans 
with both boost doses will be realized on the complete 
patients cohort. Moreover, plans realized with CyberKnife 
will be also included in the analysis.  
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Purpose/Objective: Advances in radiotherapy (RT) offer 
better treatment options for patients. The evolving 
technology increases the complexity of the treatment 
process. The quality control mechanisms used in radiotherapy 
need to evolve appropriately. Widely publicised incidents 
such as those seen in New York, Glasgow and Epinal highlight 
the need to adapt to a more systematic approach to risk 
assessment in RT. The aviation, nuclear and chemical 
industries have been developing safety tools for decades. 
Failure Mode and Effects Analysis (FMEA) and Fault Tree 
Analysis (FTA) used in these industries have been suggested 
for RT. The novel methodology presented here integrates 
human error probability modelling with components of FMEA 
and FTA and applies them in a clinical setting. 
Materials and Methods: This proposed risk assessment 
method is a hybrid of current techniques. Graphical 
representation of the RT system demonstrates the 
relationship between tasks, equipment, software and users 
involved in the treatment process. Figure 1 shows part of the 
treatment delivery process and the relevant tasks. A 
modified version of the process described by Ford et al (Med 
Phys. 2012 Dec;39(12):7272-90) was used to evaluate the RT 
pathway. The components of each process were critically 
analysed to ascertain their fault potential. The baseline 
values from the Standardized Plant Analysis Risk-Human 
Reliability Analysis (SPAR-H) methodology (2005, NRC Report) 
were used to estimate human error probability. This model 
was applied to the RT pathway (from patient CT simulation to 
final treatment) for patients with prostate cancer. 
 
 
Fig. 1 Treatment delivery process and tasks involved 
 
Results: Twenty one error modes and eighteen safety 
barriers that could affect the patients’ treatment were 
identified. The remaining tasks were classified as (a) 
irrelevant to patient safety or (b) errors acting as a process 
inhibitor. In ideal human performance conditions this model 
estimated an incident rate of 0.17% (excluding commissioning 
of treatment units). These incidents refer to any unplanned 
deviation to standard treatment. The incident rate increases 
dramatically when performance shaping factors such as 
stress, available time, complexity etc are introduced into the 
system.  
Conclusions: This novel method of risk analysis is highly 
beneficial in evaluating the effectiveness of the safety 
system in place in RT. This model can be used to assess the 
propagation of errors and highlights the areas in the RT 
process that can be improved. The human error probability is 
an estimated value which can fluctuate under different 
conditions. The use of quantitative human errors values 
allows the utilisation of FTA mathematics. This risk 
assessment technique can be used to review new processes 
and their application within the system without 
compromising patient safety. This is a fluid model that can 
be constantly updated. 
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Purpose/Objective: To evaluate a newly-developed 
automatic system for detecting errors in the planning and 
delivery of radiotherapy. 
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Materials and Methods: The error detection system 
considered here consists of three layers: 1) a software 
algorithm to detect errors in a treatment plan based on hard-
coded rules, 2) a software algorithm to detect errors based 
on a probabilistic Bayesian network model which draws from 
prior radiotherapy plans, and 3) EPID dosimetry performed 
either prior to treatment or during treatment. The multi-
layered system is intended to detect different classes of 
error and provide a 'defense in depth'. The system was 
validated against a radiotherapy incident database consisting 
of 2,599 reports collected over a 2.5 year period. Results 
presented here focus on external beam treatments with 
photon beams. The sensitivity and specificity of the 
probabilistic Bayesian error network was validated by 
introducing simulated errors and benchmarking against 
expert observers. 
Results: The sensitivity of the multi-layered system is 91%. 
EPID dosimetry alone provide a 74% sensitivity for, but only if 
used during the treatment (i.e. 'in vivo'). If performed prior 
to treatment the sensitivity falls to 6%. The rules-based 
algorithm has a sensitivity of 24%, while the probabilistic 
network has a sensitivity of 25%. The three layers provide 
complimentary detection sensitivity as observed in 
combination studies. The ROC analysis of the probabilistic 
Bayesian error network showed an AUC of 0.98, 0.88, and 
0.89 for the brain, lung and breast networks respectively. 
This compares favorably to expert observers using brain cases 
where an AUC of 0.90±0.01 was observed. 
Conclusions: When used in combination, the multi-layer 
automatic detection system is capable of detecting a vast 
majority of errors that are actually observed in clinical 
radiotherapy practice. Key components are EPID dosimetry 
performed during treatment and a probabilistic error 
prediction network. While eachcan be used on its own, these 
approaches are most effective when used in combination. 
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Purpose/Objective: EPID based in-vivo dosimetry is one of 
the most efficient and effective methods of confirming the 
correct delivery of complex radiotherapy. Software used to 
perform EPID in-vivo dosimetry typically needs to be 
commissioned for every linac and energy combination where 
EPID data is to be used. Previous work has demonstrated that 
a single energy-specific calibration model can be used to 
dosimetrically analyse EPID data acquired from multiple 
linacs by determining a linac-specific offset factor. Using this 
method has reduced the per-linac commissioning time for 
EPID based in-vivo dosimetry from 11 hours to 30 minutes.  
Auditing of the results of EPID in-vivo dosimetry performed 
on 7 clinical linacs has confirmed the validity of using these 
linac-specific offset factors. Investigation of the lifetime 
response of EPID panels has attributed the cause of these 
offset factors to differences in the software calibration of 
EPID panels rather than the dosimetric characteristics of the 
linac. 
Materials and Methods: The EPID in-vivo software was fully 
commissioned for an Elekta MLCi2 linac at 6 & 10MV and an 
Elekta Beam Modulator linac at 15MV. These energy-specific 
models were then used to analyse EPID images acquired on 
multiple linacs. From this a series of linac-specific offset 
factors was determined that would allow an EPID dosimetry 
model commissioned for one linac to be used on multiple 
other linacs. By comparing EPID in-vivo results from patients 
treated on each of these linacs over a period of 5 years the 
validity of this offset factor approach could be determined. 
The change in the linac specific offset factor has be tracked 
along the lifetime of several EPID panels. Changes in EPID 
panel response as a result of image recalibration were 
correlated with changes in the linac-specific offset factors 
applied to EPID dosimetry results. 
Results: The EPID in-vivo results of over 4000 patients 
acquired were analysed. No significant differences were 
found between patient treatments from different linacs, 
thereby validating this commissioning approach. 
The linac-offset factors determined were found to vary 
significantly (as much as 34%) when an EPID underwent image 
software calibration, despite there being no change in 
imaging or treatment hardware. This implies that it is the 
software determined response of the EPID panel and not the 
dosimetric characteristics of the linac that have the greatest 
impact on offset factors determined. 
Conclusions: The in-vivo results of over 4000 patients has 
confirmed the validity of using an energy-specific EPID in-vivo 
dosimetry model on multiple linacs when combined with 
linac-specific offset factors. Furthermore, by investigating 
the behaviour of this offset factor along the lifetime of an 
EPID panel the cause of this offset factor can be attributed to 
the software calibration of the EPID panel rather than 
dosimetric characteristics of the linac.  
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Purpose/Objective: The idea of using gold nanoparticles 
(GNP) as a high atomic number material in a tumor and 
exposing them to low energy x-rays to achieve dose 
enhancement (DE) has been previously explored. However, 
